Thiamine supplementation to cancer patients: A double edged sword

Laszlo G. Boros, James L. Brandes, Wai Nang Paul Lee, Marta Cascante, Joaquim Puigjaner, Eva Revesz, Tammy M. Bray, William J. Schirmer, W. Scott Melvin

Research output: Contribution to journalArticle

26 Scopus citations

Abstract

The objectives of this review are to (a) explain the mechanism by which thiamine (vitamin B1) promotes nucleic acid ribose synthesis and tumor cell proliferation via the nonoxidative transketolase (TK) pathway; (b) estimate the thiamine intake of cancer patients and (c) provide background information and to develop guidelines for alternative treatments with antithiamine transketolase inhibitors in the clinical setting. Clinical and experimental data demonstrate increased thiamine utilization of human tumors and its interference with experimental chemotherapy. Analysis of RNA ribose indicates that glucose carbons contribute to over 90% of ribose synthesis in cultured cervix and pancreatic carcinoma cells and that ribose is synthesized primarily through the thiamine dependent TK pathway (> 70%). Antithiamine compounds significantly inhibit nucleic acid synthesis and tumor cell proliferation in vitro and in vivo in several tumor models. The medical literature reveals little information regarding the role of the thiamine dependent TK reaction in tumor cell ribose production which is a central process in de novo nucleic acid synthesis and the salvage pathways for purines. Consequently, current thiamine administration protocols oversupply thiamine by 200% to 20,000% of the recommended dietary allowance, because it is considered harmless and needed by cancer patients. The thiamine dependent TK pathway is the central avenue which supplies ribose phosphate for nucleic acids in tumors and excessive thiamine supplementation maybe responsible for failed therapeutic attempts to terminate cancer cell proliferation. Limited administration of thiamine and concomitant treatment with transketolase inhibitors is a more rational approach to treat cancer.

Original languageEnglish (US)
Pages (from-to)595-602
Number of pages8
JournalAnticancer Research
Volume18
Issue number1 B
StatePublished - Jan 1 1998

Keywords

  • Chemotherapy resistance
  • Pentose phosphate pathways
  • Ribose synthesis
  • Transketolase reaction
  • Vitamin B

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Thiamine supplementation to cancer patients: A double edged sword'. Together they form a unique fingerprint.

  • Cite this

    Boros, L. G., Brandes, J. L., Lee, W. N. P., Cascante, M., Puigjaner, J., Revesz, E., Bray, T. M., Schirmer, W. J., & Melvin, W. S. (1998). Thiamine supplementation to cancer patients: A double edged sword. Anticancer Research, 18(1 B), 595-602.